AstraZeneca - Transforming the treatment journey: Personalized care in EGFR-mutated, MET- and HER2-altered NSCLC

Name: AstraZeneca - Transforming the treatment journey: Personalized care in EGFR-mutated, MET- and HER2-altered NSCLC
Start: 2026-12-05T12:45
End: 2026-12-05T14:15
Location: Suntec Convention Centre

ESMO Asia 2026 · 5 December 2026 · 12:45–14:15 · Hall 406

AstraZeneca - Transforming the treatment journey: Personalized care in EGFR-mutated, MET- and HER2-altered NSCLC was a session at ESMO Asia 2026 on 5 December 2026 in Singapore, with 5 speakers on record.

Speakers

Julia Rotow — Speaker The Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute
Ross A. Soo — Chair National University Cancer Institute Singapore
William Nassib William Junior — Speaker Grupo Oncoclinicas
Yi-Long Wu — Speaker Guangdong Province People's
Pei Li Stephanie Saw — Speaker NCCS - National Cancer Centre Singapore